Compass Therapeutics, Inc.
For the period ended Jun 30, 2025. Filed Aug 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 11, 2025
CMPX$0.84+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
(In thousands, except par value)
| June 30, 2025 (unaudited) | December 31, 2024 (Note 1) | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $22,856 | $43,483 |
| Marketable securities | 78,093 | 83,239 |
| Prepaid expenses and other current assets | 5,246 | 6,029 |
| Total current assets | 106,195 | 132,751 |
| Property and equipment, net | 131 | 353 |
| Operating lease, right-of-use ("ROU") asset | 9,804 | 6,731 |
| Restricted cash | 568 | 568 |
| Total assets | $116,698 | $140,403 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,595 | $2,249 |
| Accrued expenses | 10,992 | 6,287 |
| Operating lease obligations, current portion | 271 | 338 |
| Total current liabilities | 13,858 | 8,874 |
| Operating lease obligations, long-term portion | 9,633 | 6,296 |
| Total liabilities | 23,491 | 15,170 |
| Commitments and contingencies (Note 7) | ||
| Stockholders' equity: | ||
| Common stock, $0.0001 par value: 300,000 shares authorized; 138,282 and 137,820 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | 14 | 14 |
| Additional paid-in-capital | 494,182 | 489,692 |
| Accumulated other comprehensive income | 208 | 210 |
| Accumulated deficit | (401,197) | (364,683) |
| Total stockholders' equity | 93,207 | 125,233 |
| Total liabilities and stockholders' equity | $116,698 | $140,403 |
**Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.